| Bioactivity | ANG1009 is a BBB-penatrable anticancer agent. ANG1009 is cytotoxic to a variety of tumor cells and can induce cell cycle arrest. ANG1009 can be used in the study of brain cancer[1]. |
| CAS | 1220637-65-9 |
| Sequence | {Dimethylglycine Etoposide-GA}-Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-{Lys(GA-Dimethylglycine Etoposide)}-Arg-Asn-Asn-Phe-{Lys(GA-Dimethylglycine Etoposide)}-Thr-Glu-Glu-Tyr |
| Shortening | {Dimethylglycine Etoposide-GA}-TFFYGGSRG-{Lys(GA-Dimethylglycine Etoposide)}-RNNF-{Lys(GA-Dimethylglycine Etoposide)}-TEEY |
| Formula | C218H278N32O79 |
| Molar Mass | 4610.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ché C, et al. New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration. J Med Chem. 2010 Apr 8;53(7):2814-24. |
ANG1009
CAS: 1220637-65-9 F: C218H278N32O79 W: 4610.71
ANG1009 is a BBB-penatrable anticancer agent. ANG1009 is cytotoxic to a variety of tumor cells and can induce cell cycle
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.